| Keyna Marie Rolenc, LPN | |
|
5905 O St, Lincoln, NE 68510-2235 | |
| (402) 436-1655 | |
| Not Available |
| Full Name | Keyna Marie Rolenc |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 5905 O St, Lincoln, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518462852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 22559 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Keyna Marie Rolenc, LPN 5905 O St, Lincoln, NE 68510-2235 Ph: (402) 436-1655 | Keyna Marie Rolenc, LPN 5905 O St, Lincoln, NE 68510-2235 Ph: (402) 436-1655 |
News Archive
Everything published by PLoS Medicine is Open Access: freely available for anyone to read, download, redistribute and otherwise use, as long as the authorship is properly attributed.
Researchers from the San Diego Supercomputer Center (SDSC) at UC San Diego have joined forces with the Department of Radiation Oncology in the university's School of Medicine, its Department of Mathematics, and the Lawrence Livermore National Laboratory (LLNL) in a three-year, $1.5 million project to pursue novel applications of high-performance computing (HPC) in radiotherapy.
Telehealth use has surged during the pandemic at clinics that serve lower-income Americans, which allowed the clinics to maintain access to care at a time when many other health care organizations saw significant declines in utilization, according to a new RAND Corporation study.
The WHO Fracture Risk Assessment Tool (FRAX-) is an important new calculation tool, available free online at http://www.shef.ac.uk/FRAX, that is being used by a steadily increasing number of physicians around the world to calculate a patient's 10-year probability of fracture based on scientifically validated risk factors.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 9 days ago
Elizabeth Elaine Bebout, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 721 K St, Lincoln, NE 68508 Phone: 402-477-3951 Fax: 402-477-9117 | |
Lavonne Jean Hohenfeldt, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5021 Orchard St, Lincoln, NE 68504 Phone: 402-436-1164 Fax: 402-458-3264 | |
Linda Janette Deboer, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5905 O St, Lincoln, NE 68510 Phone: 402-436-1000 | |
Ms. Tara Johnson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Lpsdo 5905 O St, Lincoln, NE 68510 Phone: 402-436-1657 | |
Mrs. Kathy Hottovy, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5905 O St, Lincoln, NE 68510 Phone: 402-436-1000 Fax: 402-436-1686 | |
Kyla Dickinson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6900 Adams St, Lincoln, NE 68507 Phone: 830-377-8843 | |
Sara Bennett, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5905 O St, Lincoln, NE 68510 Phone: 402-436-1000 |